<html><head><title>Last Compo RA CAPITAL MANAGEMENT, L.P.</title></head><link rel="stylesheet" type="text/css" href="alphaleague_style.css"/>
                  <body><h2>RA CAPITAL MANAGEMENT, L.P.<br>#assets : 82<br>AUMs(M$) : 7,154</h2><table border="1" class="dataframe mystyle">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>name</th>
      <th>mktcap</th>
      <th>sector</th>
      <th>rpt_dt</th>
      <th>w</th>
      <th>name_prev</th>
      <th>rpt_dt_prev</th>
      <th>w_prev</th>
      <th>dw</th>
    </tr>
    <tr>
      <th>ticker</th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
      <th></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>ASND US</th>
      <td>ASCENDIS PHARMA A S</td>
      <td>7142.73</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#f5d2ce;">13.6</div></td>
      <td>ASCENDIS PHARMA A S</td>
      <td>30September20</td>
      <td>16.6</td>
      <td><div p style="color:black;background:#f5d2ce;">-3.0</div></td>
    </tr>
    <tr>
      <th>TGTX US</th>
      <td>TG THERAPEUTICS INC</td>
      <td>5261.45</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>6.3</td>
      <td>TG THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>4.3</td>
      <td>2.0</td>
    </tr>
    <tr>
      <th>NVAX US</th>
      <td>NOVAVAX INC</td>
      <td>13810.78</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#dbfad2;">5.9</div></td>
      <td>NOVAVAX INC</td>
      <td>30September20</td>
      <td>2.3</td>
      <td><div p style="color:black;background:#dbfad2;">3.6</div></td>
    </tr>
    <tr>
      <th>NKTX US</th>
      <td>NKARTA INC</td>
      <td>1497.47</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>4.8</td>
      <td>NKARTA INC</td>
      <td>30September20</td>
      <td>3.0</td>
      <td>1.8</td>
    </tr>
    <tr>
      <th>FMTX US</th>
      <td>FORMA THERAPEUTICS HLDGS INC</td>
      <td>1471.64</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#f5d2ce;">4.3</div></td>
      <td>FORMA THERAPEUTICS HLDGS INC</td>
      <td>30September20</td>
      <td>8.2</td>
      <td><div p style="color:black;background:#f5d2ce;">-3.9</div></td>
    </tr>
    <tr>
      <th>ARVN US</th>
      <td>ARVINAS INC</td>
      <td>3191.47</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#dbfad2;">4.3</div></td>
      <td>ARVINAS INC</td>
      <td>30September20</td>
      <td>1.5</td>
      <td><div p style="color:black;background:#dbfad2;">2.8</div></td>
    </tr>
    <tr>
      <th>CCXI US</th>
      <td>CHEMOCENTRYX INC</td>
      <td>3527.58</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>4.1</td>
      <td>CHEMOCENTRYX INC</td>
      <td>30September20</td>
      <td>4.8</td>
      <td>-0.7</td>
    </tr>
    <tr>
      <th>AVIR US</th>
      <td>ATEA PHARMACEUTICALS INC</td>
      <td>5741.36</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#dbfad2;">3.1</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">3.1</div></td>
    </tr>
    <tr>
      <th>ITOS US</th>
      <td>ITEOS THERAPEUTICS INC</td>
      <td>1082.98</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>2.0</td>
      <td>ITEOS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.9</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>KNTE US</th>
      <td>KINNATE BIOPHARMA INC</td>
      <td>1258.06</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.9</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.9</td>
    </tr>
    <tr>
      <th>492327101</th>
      <td>KEROS THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.8</td>
      <td>KEROS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.3</td>
      <td>0.5</td>
    </tr>
    <tr>
      <th>AXSM US</th>
      <td>AXSOME THERAPEUTICS INC</td>
      <td>2307.14</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.8</td>
      <td>AXSOME THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>2.6</td>
      <td>-0.8</td>
    </tr>
    <tr>
      <th>RYTM US</th>
      <td>RHYTHM PHARMACEUTICALS INC</td>
      <td>1198.77</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.7</td>
      <td>RHYTHM PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>2.0</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>89422G107</th>
      <td>TRAVERE THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.7</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.7</td>
    </tr>
    <tr>
      <th>PHAT US</th>
      <td>PHATHOM PHARMACEUTICALS INC</td>
      <td>1103.30</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.7</td>
      <td>PHATHOM PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>2.5</td>
      <td>-0.8</td>
    </tr>
    <tr>
      <th>282559103</th>
      <td>89BIO INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.6</td>
      <td>89BIO INC</td>
      <td>30September20</td>
      <td>2.2</td>
      <td>-0.6</td>
    </tr>
    <tr>
      <th>IMGN US</th>
      <td>IMMUNOGEN INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.6</td>
      <td>IMMUNOGEN INC</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>1.2</td>
    </tr>
    <tr>
      <th>RCKT US</th>
      <td>ROCKET PHARMACEUTICALS INC COM</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.6</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.6</td>
    </tr>
    <tr>
      <th>ADVM US</th>
      <td>ADVERUM BIOTECHNOLOGIES INC</td>
      <td>1081.92</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.4</td>
      <td>ADVERUM BIOTECHNOLOGIES INC</td>
      <td>30September20</td>
      <td>1.7</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>ZGNX US</th>
      <td>ZOGENIX INC</td>
      <td>1039.99</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.4</td>
      <td>ZOGENIX INC</td>
      <td>30September20</td>
      <td>1.7</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>OLMA US</th>
      <td>OLEMA PHARMACEUTICALS INC</td>
      <td>1578.23</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.4</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.4</td>
    </tr>
    <tr>
      <th>69353Y103</th>
      <td>PMV PHARMACEUTICALS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.4</td>
      <td>PMV PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>PCVX US</th>
      <td>VAXCYTE INC</td>
      <td>1135.21</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td><div p style="color:black;background:#f5d2ce;">1.3</div></td>
      <td>VAXCYTE INC</td>
      <td>30September20</td>
      <td>4.7</td>
      <td><div p style="color:black;background:#f5d2ce;">-3.4</div></td>
    </tr>
    <tr>
      <th>MGNX US</th>
      <td>MACROGENICS INC</td>
      <td>919.02</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.3</td>
      <td>MACROGENICS INC</td>
      <td>30September20</td>
      <td>2.0</td>
      <td>-0.7</td>
    </tr>
    <tr>
      <th>449585108</th>
      <td>IGM BIOSCIENCES INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.2</td>
      <td>IGM BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>1.3</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>BDTX US</th>
      <td>BLACK DIAMOND THERAPEUTICS INC</td>
      <td>1020.53</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.1</td>
      <td>BLACK DIAMOND THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.4</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>SBTX US</th>
      <td>SILVERBACK THERAPEUTICS INC</td>
      <td>1369.66</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.1</td>
    </tr>
    <tr>
      <th>SLDB US</th>
      <td>SOLID BIOSCIENCES INC</td>
      <td>359.43</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.0</td>
      <td>SOLID BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>0.9</td>
    </tr>
    <tr>
      <th>89620X506</th>
      <td>TRILLIUM THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>1.0</td>
      <td>TRILLIUM THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.6</td>
      <td>-0.6</td>
    </tr>
    <tr>
      <th>FPRX US</th>
      <td>FIVE PRIME THERAPEUTICS INC</td>
      <td>717.83</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.0</td>
    </tr>
    <tr>
      <th>KALA US</th>
      <td>KALA PHARMACEUTICALS INC</td>
      <td>439.01</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>1.0</td>
      <td>KALA PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>1.4</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>LEGN US</th>
      <td>LEGEND BIOTECH CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.9</td>
      <td>LEGEND BIOTECH CORP</td>
      <td>30September20</td>
      <td>1.3</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>45720L107</th>
      <td>INHIBRX INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.9</td>
      <td>INHIBRX INC</td>
      <td>30September20</td>
      <td>0.7</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>WVE US</th>
      <td>WAVE LIFE SCIENCES LTD</td>
      <td>424.98</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.8</td>
      <td>WAVE LIFE SCIENCES LTD</td>
      <td>30September20</td>
      <td>1.2</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>14147L108</th>
      <td>CARDIFF ONCOLOGY INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.8</td>
      <td>CARDIFF ONCOLOGY INC</td>
      <td>30September20</td>
      <td>0.8</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>26818M108</th>
      <td>DYNE THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.8</td>
      <td>DYNE THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.0</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>CRIS US</th>
      <td>CURIS INC</td>
      <td>91.05</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.8</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.8</td>
    </tr>
    <tr>
      <th>PACB US</th>
      <td>PACIFIC BIOSCIENCES OF CALIFORNIA INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.7</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.7</td>
    </tr>
    <tr>
      <th>CNST US</th>
      <td>CONSTELLATION PHARMCETICLS INC</td>
      <td>1390.26</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.7</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.7</td>
    </tr>
    <tr>
      <th>GERN US</th>
      <td>GERON CORP</td>
      <td>480.75</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.6</td>
      <td>GERON CORP</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>00973J101</th>
      <td>AKOUOS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.6</td>
      <td>AKOUOS INC</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>STRO US</th>
      <td>SUTRO BIOPHARMA INC</td>
      <td>721.60</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.6</td>
      <td>SUTRO BIOPHARMA INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>12529R107</th>
      <td>C4 THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.6</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.6</td>
    </tr>
    <tr>
      <th>ARDX US</th>
      <td>ARDELYX INC</td>
      <td>538.69</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.5</td>
      <td>ARDELYX INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>ORTX US</th>
      <td>ORCHARD THERAPEUTICS PLC</td>
      <td>790.03</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.5</td>
      <td>ORCHARD THERAPEUTICS PLC</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>45790W108</th>
      <td>INOZYME PHARMA INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.5</td>
      <td>INOZYME PHARMA INC</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>15678U128</th>
      <td>CEREVEL THERAPEUTICS HLDNG INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.5</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.5</td>
    </tr>
    <tr>
      <th>RLAY US</th>
      <td>RELAY THERAPEUTICS INC</td>
      <td>3400.53</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.5</td>
      <td>RELAY THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.7</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>VRNA US</th>
      <td>VERONA PHARMA PLC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.4</td>
      <td>VERONA PHARMA PLC</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>ARQT US</th>
      <td>ARCUTIS BIOTHERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.4</td>
      <td>ARCUTIS BIOTHERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>517125100</th>
      <td>LARIMAR THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.4</td>
      <td>LARIMAR THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>SNDX US</th>
      <td>SYNDAX PHARMACEUTICALS INC</td>
      <td>816.54</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>SYNDAX PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>CNCE US</th>
      <td>CONCERT PHARMACEUTICALS INC</td>
      <td>186.94</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>CONCERT PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>698340106</th>
      <td>PANDION THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>PANDION THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>STSA US</th>
      <td>SATSUMA PHARMACEUTICALS INC</td>
      <td>100.14</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>SATSUMA PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>ALEC US</th>
      <td>ALECTOR INC</td>
      <td>1374.26</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.3</td>
      <td>ALECTOR INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>SCPH US</th>
      <td>SCPHARMACEUTICALS INC</td>
      <td>165.42</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>SCPHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>92243A200</th>
      <td>VAXART INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>VAXART INC</td>
      <td>30September20</td>
      <td>1.3</td>
      <td>-1.1</td>
    </tr>
    <tr>
      <th>56854Q200</th>
      <td>MARINUS PHARMACEUTICALS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>ORIC US</th>
      <td>ORIC PHARMACEUTICALS INC</td>
      <td>985.20</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>67576A100</th>
      <td>OCULAR THERAPEUTIX INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>OCULAR THERAPEUTIX INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>MIST US</th>
      <td>MILESTONE PHARMACEUTICALS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.2</td>
      <td>MILESTONE PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>RPTX US</th>
      <td>REPARE THERAPEUTICS INC</td>
      <td>1032.30</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>REPARE THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>CRNX US</th>
      <td>CRINETICS PHARMACEUTICALS INC</td>
      <td>426.04</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>CRINETICS PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>G4444C102</th>
      <td>HELIX ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>G4411D109</th>
      <td>HEALTH SCIENCES ACQ CORP 2</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>HEALTH SCIENCES ACQ CORP 2</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>G3710A121</th>
      <td>FRAZIER LIFESCIENCES ACQUISITION CO</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>G3166W106</th>
      <td>ARYA SCIENCES ACQUISITION CO</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>ARYA SCIENCES ACQUISITION CO</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>G0904B105</th>
      <td>BCLS ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>05492W103</th>
      <td>BCTG ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>BCTG ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>19240Q201</th>
      <td>COGENT BIOSCIENCES INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>33836P105</th>
      <td>5 01 ACQUISITION CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>TXMD US</th>
      <td>THERAPEUTICSMD INC</td>
      <td>556.30</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>55234L105</th>
      <td>LYRA THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>LYRA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>60463E202</th>
      <td>MIRAGEN THERAPEUTICS INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>PASG US</th>
      <td>PASSAGE BIO INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>PASSAGE BIO INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>ADAP US</th>
      <td>ADAPTIMMUNE THERAPEUTICS PLC</td>
      <td>865.35</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.1</td>
      <td>ADAPTIMMUNE THERAPEUTICS PLC</td>
      <td>30September20</td>
      <td>1.6</td>
      <td>-1.5</td>
    </tr>
    <tr>
      <th>74319B502</th>
      <td>PROFOUND MEDICAL CORP</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>15678U102</th>
      <td>CEREVEL THERAPEUTICS HLDNG INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>XFOR US</th>
      <td>X4 PHARMACEUTICALS INC</td>
      <td>93.48</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>X4 PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>IMRA US</th>
      <td>IMARA INC</td>
      <td>0.00</td>
      <td>0</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>IMARA INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>OVID US</th>
      <td>OVID THERAPEUTICS INC</td>
      <td>138.43</td>
      <td>Health Care</td>
      <td>31December20</td>
      <td>0.0</td>
      <td>OVID THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>81750R102</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>SERES THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>2.4</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.4</div></td>
    </tr>
    <tr>
      <th>28249H104</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>EIDOS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.9</td>
      <td>-1.9</td>
    </tr>
    <tr>
      <th>761299106</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>RETROPHIN INC</td>
      <td>30September20</td>
      <td>1.5</td>
      <td>-1.5</td>
    </tr>
    <tr>
      <th>75955J402</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>RELMADA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>74140Y101</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>PREVAIL THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>303020101</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>FS DEV CORP</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>36338D108</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>GALERA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>92337C104</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>VERASTEM INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>G31655114</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>ARYA SCIENCES ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>29668H708</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>ESSA PHARMA INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>15117B202</th>
      <td>-</td>
      <td>0.00</td>
      <td>0</td>
      <td>-</td>
      <td>-</td>
      <td>CELLDEX THERAPEUTICS INC NEW</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
  </tbody>
</table></body></html>.